CCL20 and bacterial infectious disease: The expression of both in vivo and in vitro CCL20 mRNA has been already evidenced by Abiko et al. in 2003, who suggested that CCL20 contributes to the oral immune response to bacterial infections such as Actinobacillus actinomycetemcomitans and may be involved in the progression of OSCC [29].